- Omicron and CovAb™
- Role of IgA as a neutralizing antibody
- Post Vaccination and CovAb™ studies
- CovAb™ Oral Fluid Antibody Test for Assessment of Immune Response to Pfizer-BioNTECH Vaccination
- PERFORMANCE AND UTILITY OF AN ORAL FLUID-BASED RAPID POINT-OF-CARE TEST FOR SARS-COV-2 ANTIBODY RESPONSE FOLLOWING COVID-19 INFECTION OR VACCINATION
- CovAb™ Oral Fluid Comprehensive Antibody Test for Assessment of Immune Response to COVID-19 Vaccination
- Longevity of antibodies
- CovAb™ Detection of Neutralizing antibodies
- Covid-19 Mutations
Omicron and CovAb™
Does CovAb™ detect Omicron variant antibodies?
Role of IgA as a neutralizing antibody
IgA dominates the early neutralizing antibody response to SARS-CoV-2
Delphine Sterlin, Alexis Mathian, Makoto Miyara, Audrey Mohr, François Anna, Laetitia Claër, Paul Quentric1, Jehane Fadlallah, Hervé Devilliers, Pascale Ghillani, Cary Gunn, Rick Hockett, Sasi Mudumba, Amélie Guihot, Charles-Edouard Luyt, Julien Mayaux, Alexandra Beurton, Salma Fourati, Timothée Bruel, Olivier Schwartz, Jean-Marc Lacorte, Hans Yssel, Christophe Parizot, Karim Dorgham, Pierre Charneau, Zahir Amoura, Guy Gorochov
Science Translational Medicine 20 Jan 2021: Vol. 13, Issue 577, eabd2223
The role of IgA in COVID-19
Yin Xia Chao, Olaf Rötzschke, Eng-King Tan
Brain, Behavior, and Immunity 2020 87:182-183
Serum IgA, IgM, and IgG responses in COVID-19
Huan Ma, Weihong Zeng, Hongliang He, Dan Zhao, Dehua Jiang, Peigen Zhou, Linzhao Cheng,
Yajuan Li , Xiaoling Ma & Tengchuan Jin
Cellular & Molecular Immunology 17, 773–775(2020)
Post Vaccination and CovAb™ studies
CovAb™ Oral Fluid Antibody Test for Assessment of Immune Response to Pfizer-BioNTECH Vaccination
PERFORMANCE AND UTILITY OF AN ORAL FLUID-BASED RAPID POINT-OF-CARE TEST FOR SARS-COV-2 ANTIBODY RESPONSE FOLLOWING COVID-19 INFECTION OR VACCINATION
Paturi V. Rao, Dhanalakshmi Nair-Shaef, Siting Chen, Steven C. Kazmierczak, Charles T. Roberts Jr., Srinivasa R. Nagalla
medRxiv 2021.06.28.21259657
CovAb™ Oral Fluid Comprehensive Antibody Test for Assessment of Immune Response to COVID-19 Vaccination
Longevity of antibodies
SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo’
Dorigatti, I., Lavezzo, E., Manuto, L. et al.
Nat Commun 12, 4383 (2021)
The Power of Antibody-Based Surveillance
Galit Alter, Ph.D., and Robert Seder, M.D.
N Engl J Med 2020; 383:1782-1784
Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
F. Javier Ibarrondo, Ph.D., Jennifer A. Fulcher, M.D., Ph.D., David Goodman-Meza, M.D., Julie Elliott, M.S., Christian Hofmann, Ph.D., Mary A. Hausner, M.S., Kathie G. Ferbas, Ph.D., Nicole H. Tobin, M.D., Grace M. Aldrovandi, M.D., Otto O. Yang, M.D.
N Engl J Med 2020; 383:1085-1087
CovAb™ Detection of Neutralizing antibodies
CovAb™ and Neutralizing Antibodies
Sensitivity and specificity of SARS-CoV-2 S1 subunit in COVID-19 serology assays
Ying Tian, Chaoyang Lian, Yingying Chen, Dong Wei, Xinxin Zhang, Yun Ling, Ying Wang & Leng-Siew Yeap
Cell Discovery volume 6, Article number: 75 (2020)
Covid-19 Mutations
CovAb™ ability to detect antibodies of variants
The Spike Proteins of SARS-CoV-2 B.1.617 and B.1.618 Variants Identified in India Provide Partial Resistance to Vaccine-elicited and Therapeutic Monoclonal Antibodies
Takuya Tada, Hao Zhou, Belinda M. Dcosta, Marie I. Samanovic, Mark J. Mulligan, Nathaniel R. Landau
bioRxiv 2021.05.14.444076
The coronavirus is mutating — does it matter?
Ewen Callaway
Nature 585, 174-177 (2020)